I think that ideally it would be more advantageous if that partner Was in the biotech field, not sure what non biotech entity could take this up, any ideas?
Biotech partner would have the advantage of established network, distribution and marketing in place in this field, looking at it from a layman’s point of view but it does seem to make sense until I am enlightened otherwise.
I think that ideally it would be more advantageous if that...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.50 |
Change
0.450(2.36%) |
Mkt cap ! $366.1M | |||
| Open | High | Low | Value | Volume |
| $19.05 | $19.50 | $18.90 | $65.93K | 3.417K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.50 | 2909 | 3 |
View Market Depth
| Last trade - 11.44am 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.39 |
Change
0.450 ( 2.05 %) |
||||
| Open | High | Low | Volume | ||
| $19.00 | $19.39 | $19.00 | 224 | ||
| Last updated 11.17am 12/06/2024 ? | |||||
| AVR (ASX) Chart |